Cahill Represents Initial Purchasers in €275 Million Acquisition Financing for IMS Health
Date: 03/30/15
Cahill represented the joint book-running managers and co-managers in connection with the Rule 144A offering of €275,000,000 aggregate principal amount of 4.125% Senior Notes due 2023 by IMS Health Incorporated, a leading global information and technology services company. Proceeds from the offering will be used in connection with IMS’s acquisition of certain customer relationship management and strategic data businesses of Cegedim, N.A.